Capstone Investment Advisors’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.73M | Sell |
93,700
-127,600
| -58% | -$9.83M | 0.01% | 371 |
|
|
2025
Q4 | $17.6M | Sell |
221,300
-79,800
| -27% | -$6.29M | 0.03% | 187 |
|
|
2025
Q3 | $22.7M | Buy |
301,100
+75,900
| +34% | +$5.2M | 0.04% | 189 |
|
|
2025
Q2 | $15.5M | Sell |
225,200
-57,400
| -20% | -$3.76M | 0.04% | 182 |
|
|
2025
Q1 | $19.1M | Buy |
282,600
+1,000
| +0.4% | +$59.8K | 0.05% | 179 |
|
|
2024
Q4 | $12.6M | Buy |
281,600
+40,500
| +17% | +$2.27M | 0.03% | 312 |
|
|
2024
Q3 | $15.2M | Sell |
241,100
-60,700
| -20% | -$3.54M | 0.05% | 226 |
|
|
2024
Q2 | $17.8M | Buy |
301,800
+62,000
| +26% | +$3.88M | 0.06% | 206 |
|
|
2024
Q1 | $19.1M | Sell |
239,800
-134,400
| -36% | -$10.3M | 0.07% | 184 |
|
|
2023
Q4 | $29.5M | Buy |
374,200
+143,900
| +62% | +$10.2M | 0.09% | 156 |
|
|
2023
Q3 | $16.1M | Buy |
230,300
+22,500
| +11% | +$1.59M | 0.07% | 179 |
|
|
2023
Q2 | $14.4M | Buy |
207,800
+8,500
| +4% | +$605K | 0.07% | 193 |
|
|
2023
Q1 | $14.8M | Buy |
199,300
+70,400
| +55% | +$5.9M | 0.07% | 182 |
|
|
2022
Q4 | $12M | Buy |
128,900
+8,400
| +7% | +$811K | 0.09% | 195 |
|
|
2022
Q3 | $11.5M | Sell |
120,500
-48,200
| -29% | -$4.77M | 0.07% | 205 |
|
|
2022
Q2 | $15.6M | Sell |
168,700
-460,500
| -73% | -$44.9M | 0.08% | 171 |
|
|
2022
Q1 | $63.7M | Sell |
629,200
-945,500
| -60% | -$99.3M | 0.18% | 73 |
|
|
2021
Q4 | $162M | Buy |
1,574,700
+395,200
| +34% | +$36.5M | 0.27% | 71 |
|
|
2021
Q3 | $100M | Buy |
1,179,500
+64,900
| +6% | +$5.44M | 0.2% | 101 |
|
|
2021
Q2 | $93M | Buy |
1,114,600
+100,000
| +10% | +$8.19M | 0.21% | 101 |
|
|
2021
Q1 | $76.3M | Buy |
1,014,600
+596,300
| +143% | +$43.4M | 0.22% | 91 |
|
|
2020
Q4 | $28.6M | Buy |
418,300
+190,700
| +84% | +$12.4M | 0.1% | 174 |
|
|
2020
Q3 | $13.3M | Buy |
227,600
+42,100
| +23% | +$2.62M | 0.07% | 249 |
|
|
2020
Q2 | $12.1M | Buy |
185,500
+127,200
| +218% | +$8.01M | 0.08% | 216 |
|
|
2020
Q1 | $3.46M | Sell |
58,300
-638,600
| -92% | -$42.6M | 0.06% | 371 |
|
|
2019
Q4 | $51.8M | Buy |
696,900
+313,900
| +82% | +$22M | 0.28% | 73 |
|
|
2019
Q3 | $24.2M | Buy |
383,000
+81,900
| +27% | +$4.85M | 0.17% | 124 |
|
|
2019
Q2 | $16.4M | Buy |
301,100
+87,900
| +41% | +$4.73M | 0.12% | 187 |
|
|
2019
Q1 | $11.5M | Buy |
213,200
+87,500
| +70% | +$5.4M | 0.11% | 189 |
|
|
2018
Q4 | $8.24M | Buy |
125,700
+44,500
| +55% | +$3.32M | 0.1% | 163 |
|
|
2018
Q3 | $6.39M | Buy |
81,200
+58,600
| +259% | +$4.19M | 0.07% | 212 |
|
|
2018
Q2 | $1.45M | Buy |
+22,600
| New | +$1.49M | 0.02% | 325 |
|
|
2017
Q2 | – | Sell |
-4,600
| Closed | -$359K | – | 687 |
|
|
2017
Q1 | $359K | Sell |
4,600
-7,400
| -62% | -$591K | 0.01% | 666 |
|
|
2016
Q4 | $945K | Buy |
+12,000
| New | +$971K | 0.03% | 441 |
|
Other funds holding CVS
VCM
VPM
Capstone Investment Advisors's CVS Position: Q1 2026 in Review
Capstone Investment Advisors sold out of CVS Health (CVS) in Q1 2026, closing a stake of 6,411 shares — an estimated $494K sold.
Capstone Investment Advisors first reported a position in CVS in Q2 2014 and held it in 29 quarters. The position peaked at $12.2M in Q2 2023. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Capstone Investment Advisors reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
- Capstone Investment Advisors sold 6,411 CVS Health shares in Q1 2026, an estimated $494K.
- Capstone Investment Advisors first reported a position in CVS Health in Q2 2014 and held it in 29 quarters.
- Capstone Investment Advisors's CVS Health position peaked at $12.2M in Q2 2023.
- 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.